Sort
261,768 grants matching “gene therapy”
Improving HbF induction by inhibiting epigenetic target enzymes
$1,707,550James Douglas Engel · University Of Michigan At Ann Arbor · U01 · FY2014 · HL
Function Of Skeletal Matrix Genes
$1,707,453Marian F Young · National Institute Of Dental & Craniofacial Research · ZIA · FY2018 · DE
rAAV-CNGB3 Gene Therapy for Achromatopsia: Translational Research Studies
$1,707,387William W Hauswirth · University Of Florida · R24 · FY2014 · EY
The Johns Hopkins Translational ImmunoEngineering (JH-TIE) BTRC
$1,707,351Jonathan P Schneck · Johns Hopkins University · P41 · FY2019 · EB
Development and conduct of allogeneic stem cell transplant and autologous stem cell gene therapy for inherited immune deficiencies
$1,707,308Elizabeth Kang · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
Molecular Mechanisms Of Hepatitis B Viral infection, Pathogenesis And Persistence
$1,707,254T. Jake Liang · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2022 · DK
Biological Breast Cancer Classification by qRT-PCR
$1,707,248Matthew J Ellis · Washington University · U01 · FY2009 · CA
Synergistic Enhancement of ER proteostasis, trafficking, and lysosomes as treatments for Dementia with Lewy bodies and Parkinsonâs disease-dementia
$1,707,089Joseph R Mazzulli · Northwestern University At Chicago · R61 · FY2024 · NS
TNF Signaling, Cell Death and Cancer
$1,706,389Zheng-Gang Liu · Division Of Clinical Sciences - Nci · ZIA · FY2025 · CA
Combinatorial effects of PTMs on a-Synuclein structure, function and aggregation
$1,706,062Elizabeth Rhoades · University Of Pennsylvania · RF1 · FY2022 · NS
Targets for Therapy for Carcinomas of the Lung
$1,705,771Mark G Kris · Sloan-Kettering Inst Can Research · P01 · FY2020 · CA
Targets for Therapy for Carcinomas of the Lung
$1,705,771Mark G Kris · Sloan-Kettering Inst Can Research · P01 · FY2021 · CA
Pharmacology And Physiology Of The Substantia Nigra And Basal Ganglia
$1,705,745Judith Richmon Walters · Neurological Disorders And Stroke · Z01 · FY2007 · NS
STEM CELL THERAPY OF CONGENITAL DEFECTS IN HEMATOPOIESIS
$1,705,452Dana-Farber Cancer Institute · P50 · FY2000 · HL
Pancreatic Cancer Genetic Epidemiology Consortium (PACGENE)
$1,705,171Gloria M. Petersen · Mayo Clinic Rochester · R01 · FY2008 · CA
Functional and Structural Brain Circuits Underlying Smoking
$1,705,084Elliot A Stein · National Institute On Drug Abuse · ZIA · FY2017 · DA
NHLBI MAINTENANCE OF CANINE MODELS OF HUMAN BLEEDING DISORDERS
$1,705,066 · N01 · FY2025 · HL
NATIONAL HEAT, LUNG AND BLOOD INSTITUTE (NHLBI) GENE THERAPY RESOURCE PROGRAM
$1,704,813Michael J. Gilbreath · · N01 · FY2007 · HL
Genetic susceptibility to unrelated donor stem cell transplant-related mortality
$1,704,501Theresa E Hahn · Roswell Park Cancer Institute Corp · R01 · FY2011 · HL
Imprinting a Connectome: Developmental Circuit Approach to Mental Illness
$1,704,360Takao K Hensch · Harvard University · P50 · FY2012 · MH
Retinoids in Vision
$1,704,318Krzysztof Palczewski · University Of California-Irvine · R01 · FY2025 · EY
Mechanisms of non-classical multidrug resistance in cancer
$1,704,193Michael Gottesman · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Identification and Development of Tau-Lowering Small-Molecule Drugs
$1,703,867Lennart Mucke · J. David Gladstone Institutes · R56 · FY2019 · AG
Modulating Cancer Stem Cell Signaling in Thoracic Malignancies
$1,703,808David Schrump · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Gene Replacement Therapy in Hematopoietic Stem Cells
$1,703,644Mary C Dinauer · Indiana Univ-Purdue Univ At Indianapolis · P01 · FY2006 · HL